Frustrated that their discovery scientists spend more time looking for and preparing relevant Life Science Data than analysing it, Genestack’s pharmaceutical clients challenged the company to solve this industry problem.
Genestack supports members of the Milner Therapeutics Institute deliver an ecosystem approach for drug discovery.
New insights gained from genomic information are changing the way we diagnose disease, develop drugs and test for toxicity but there is a shortage of people with the skills and tools needed to analyse and interpret these data. To help build these skills the first Cambridge Bioinformatics Hackathon is to take place in the city on 25-27th September 2017.
It is now possible for non-bioinformaticians to create knowledge-networks – a powerful way for biologists to visualise deep connections between genes and phenotypes – quickly and efficiently thanks to the integration of Rothamsted Research’s open-source KnetMiner software into the Genestack platform.
Many key scientists lack essential skills in bioinformatics and this is potentially a bottleneck for therapeutic research in big pharma. Dr Misha Kapushesky, CEO of Genestack, will discuss how increasing pressure on bioinformaticians is slowing the pace of discovery in a webinar ‘Next-generation Sequencing: New Business Models in Diagnostics and Drug Development’ organised by Frost & Sullivan on 9th August.